AI & Intelligence
Clinical and Bio-Genomics AI.
Artificial intelligence is a core part of MyRxWallet DAO, LLC's strategic role — but the planned AI/ML engine does not yet exist. No code had been written for that specific engine as of the SEC filing, with development anticipated after funding and data-partnership activities.
Planned Capabilities
Two areas of planned AI development.
Planned / Not Yet BuiltClinical AI
Planned decision-support and clinical-intelligence models.
Bio-Genomics AI
Planned analytics connecting genomic and biological data with clinical intelligence, developed in coordination with the broader ecosystem's life-sciences work.
Status: No AI/ML clinical engine currently exists. Development is anticipated to
follow funding and data-partnership activities. See Technology Roadmap
for the current-versus-planned breakdown across the full platform.